Point72 Asset Management’s Immunic IMUX Stock Holding History

Point72 Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166K	Buy	+10,806	New	+$133K	﹤0.01%	3587
2023 Q2	–	Sell	-71,466	Closed	-$1.06M	–	2455
2023 Q1	$1.06M	Hold	71,466	–	–	﹤0.01%	1096
2022 Q4	$1M	Sell	71,466 -61,034	-46%	-$1.66M	﹤0.01%	1049
2022 Q3	$4.19M	Hold	132,500	–	–	0.02%	770
2022 Q2	$4.6M	Buy	132,500 +60,000	+83%	+$3.84M	0.02%	730
2022 Q1	$8.19M	Hold	72,500	–	–	0.03%	569
2021 Q4	$6.94M	Buy	72,500 +10,000	+16%	+$901K	0.03%	603
2021 Q3	$5.53M	Buy	+62,500	New	+$6.15M	0.02%	640
2021 Q2	–	Sell	-43,305	Closed	-$6.9M	–	1062
2021 Q1	$6.9M	Buy	43,305 +22,855	+112%	+$3.88M	0.03%	515
2020 Q4	$3.13M	Buy	+20,450	New	+$3.67M	0.02%	662
2020 Q3	–	Sell	-17,500	Closed	-$2.12M	–	999
2020 Q2	$2.12M	Buy	+17,500	New	+$1.78M	0.01%	582

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Point72 Asset Management's IMUX Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Immunic (IMUX) in Q2 2026: 10,806 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #3587 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in IMUX as recently as Q1 2023.

Point72 Asset Management first reported a position in IMUX in Q2 2020 and has held it in 11 quarters since. The position peaked at $8.19M in Q1 2022. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

Point72 Asset Management held 10,806 shares of Immunic worth $166K as of Q2 2026.
Immunic was a new Point72 Asset Management position in Q2 2026.
Immunic made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3587 holding.
Point72 Asset Management first reported a position in Immunic in Q2 2020 and has held it in 11 quarters since.
Point72 Asset Management's Immunic position peaked at $8.19M in Q1 2022.
55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.